meeting on vasculitiscanvasc.com/pdf/canvasc2012program_slides.pdfpart 1 ‐8:30 to 10:45am 8:40...
TRANSCRIPT
![Page 1: Meeting on Vasculitiscanvasc.com/pdf/canvasc2012Program_slides.pdfPart 1 ‐8:30 to 10:45AM 8:40 ‐Large vessel vasculitides yClinical updates in LVV –Dr. Nader Khalidi yUpdates](https://reader035.vdocuments.us/reader035/viewer/2022070716/5edb54c7ad6a402d66657f18/html5/thumbnails/1.jpg)
2nd Annual Scientific Meeting on Vasculitis
Montréal Centre Mont-Royal
22 November 2012
![Page 2: Meeting on Vasculitiscanvasc.com/pdf/canvasc2012Program_slides.pdfPart 1 ‐8:30 to 10:45AM 8:40 ‐Large vessel vasculitides yClinical updates in LVV –Dr. Nader Khalidi yUpdates](https://reader035.vdocuments.us/reader035/viewer/2022070716/5edb54c7ad6a402d66657f18/html5/thumbnails/2.jpg)
Part 1 ‐ 8:30 to 10:45AM8:40 ‐ Large vessel vasculitides
Clinical updates in LVV – Dr. Nader KhalidiUpdates on LVV treatment – Dr. Patrick Liang
9:20 ‐ ANCA testing: how do we know the result is reliable – Dr. Donglai Ma (Euroimmun)
9h50 – ANCA‐associated vasculitidesClinical updates and gold‐standard therapy – Dr. Simon CaretteRituximab and biologics – Dr. Michelle Goulet
10h45 – 10 minutes Break
![Page 3: Meeting on Vasculitiscanvasc.com/pdf/canvasc2012Program_slides.pdfPart 1 ‐8:30 to 10:45AM 8:40 ‐Large vessel vasculitides yClinical updates in LVV –Dr. Nader Khalidi yUpdates](https://reader035.vdocuments.us/reader035/viewer/2022070716/5edb54c7ad6a402d66657f18/html5/thumbnails/3.jpg)
Part 2 ‐ 11:00AM to 12:05PMVasculitis STUDIES in Canada and CanVasc projects
Ongoing CanVasc activities and studies ‐ Dr. Christian PagnouxOpportunities for vasculitis studies in Canada – Dr. Susan Benseler
Ongoing non‐CanVasc studies in Canada ‐ Dr. Christian Pagnoux
12h05 – 13h15 Lunch
![Page 4: Meeting on Vasculitiscanvasc.com/pdf/canvasc2012Program_slides.pdfPart 1 ‐8:30 to 10:45AM 8:40 ‐Large vessel vasculitides yClinical updates in LVV –Dr. Nader Khalidi yUpdates](https://reader035.vdocuments.us/reader035/viewer/2022070716/5edb54c7ad6a402d66657f18/html5/thumbnails/4.jpg)
Part 3 & 4 ‐ 1:15 to 2:45PM1h15 ‐ CanVasc Website
‐ Dr. Christian Pagnoux
1h25 ‐ Imaging in vasculitides (LVV): PET and MRI ‐ Dr. Ryan Rebello
1h55 ‐ ANCA‐ Associated Vasculitis : The Cambridge (U.K.) experience – Dr. Rachel Jones
2h45 – 10 minutes Break
![Page 5: Meeting on Vasculitiscanvasc.com/pdf/canvasc2012Program_slides.pdfPart 1 ‐8:30 to 10:45AM 8:40 ‐Large vessel vasculitides yClinical updates in LVV –Dr. Nader Khalidi yUpdates](https://reader035.vdocuments.us/reader035/viewer/2022070716/5edb54c7ad6a402d66657f18/html5/thumbnails/5.jpg)
Part 5 & 6 ‐ 3:00 to 5:00PM3h00 ‐ CNS vasculitisPediatric CNS vasculitis and BrainWorks – Dr. Susan Benseler
Adult CNS vasculitis and InterSpace – Dr. Sylvain Lanthier
3h45 ‐Meet the Experts: difficult vasculitis cases – Panel of CanVasc core members
4h45 Conclusion
![Page 6: Meeting on Vasculitiscanvasc.com/pdf/canvasc2012Program_slides.pdfPart 1 ‐8:30 to 10:45AM 8:40 ‐Large vessel vasculitides yClinical updates in LVV –Dr. Nader Khalidi yUpdates](https://reader035.vdocuments.us/reader035/viewer/2022070716/5edb54c7ad6a402d66657f18/html5/thumbnails/6.jpg)
Thanks to the following pharmaceutical companies for their funding support
PLATINUM SUPPORT
Abbott Immunology
Janssen‐Cilag
Euroimmun
Pfizer/Amgen
SILVER SUPPORT
Hoffman ‐ La Roche
![Page 7: Meeting on Vasculitiscanvasc.com/pdf/canvasc2012Program_slides.pdfPart 1 ‐8:30 to 10:45AM 8:40 ‐Large vessel vasculitides yClinical updates in LVV –Dr. Nader Khalidi yUpdates](https://reader035.vdocuments.us/reader035/viewer/2022070716/5edb54c7ad6a402d66657f18/html5/thumbnails/7.jpg)
Toronto2014
![Page 8: Meeting on Vasculitiscanvasc.com/pdf/canvasc2012Program_slides.pdfPart 1 ‐8:30 to 10:45AM 8:40 ‐Large vessel vasculitides yClinical updates in LVV –Dr. Nader Khalidi yUpdates](https://reader035.vdocuments.us/reader035/viewer/2022070716/5edb54c7ad6a402d66657f18/html5/thumbnails/8.jpg)